Appointment of Head of Business Development

AI SummaryClose X

ECO Animal Health Group plc announces the appointment of Dr Andrew Winder as Head of Business Development, effective May 11, 2026, to identify strategic growth opportunities for its R&D pipeline. Dr. Winder brings extensive experience from Norbrook Laboratories Ltd, where he secured multiple co-development and distribution agreements and developed a global portfolio strategy that doubled the company's project pipeline. His role will focus on in-licensing partnerships to expand ECO's R&D pipeline, coinciding with the EU commercial launch of its poultry vaccine, ECOVAXXIN® MS.

Disclaimer*

UK 100

Latest directors dealings